Catheter reprices stock options for CEO and CFO
Catheter Precision repriced outstanding stock options for CEO David A. Jenkins and CFO Philip Anderson to $0.152 per share (pre-reverse split), effective with its 1-for-10 reverse split.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.